Detalhe da pesquisa
1.
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.
N Engl J Med
; 384(13): 1216-1226, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33789010
2.
Epidemiological and biological associations between cardiovascular disease and kidney stone formation: A systematic review and meta-analysis.
Nutr Metab Cardiovasc Dis
; 34(3): 559-568, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38431384
3.
Rare variants in the sodium-dependent phosphate transporter gene SLC34A3 explain missing heritability of urinary stone disease.
Kidney Int
; 104(5): 975-984, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414395
4.
PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2.
Kidney Int
; 103(1): 207-217, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36007597
5.
ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria.
Pediatr Nephrol
; 38(2): 403-415, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35552824
6.
A report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3.
Kidney Int
; 100(3): 621-635, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33865885
7.
A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.
Pediatr Nephrol
; 32(5): 781-790, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27924398
8.
Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium.
Kidney Int Rep
; 8(10): 2029-2042, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37849991
9.
Extracellular pyrophosphate in the kidney: how does it get there and what does it do?.
Nephron Physiol
; 120(4): p33-8, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23075758
10.
Primary hyperoxaluria: the adult nephrologist's point of view.
Clin Kidney J
; 15(Suppl 1): i29-i32, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35711295
11.
Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1.
Kidney Int Rep
; 7(3): 494-506, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35257062
12.
Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry.
Kidney Int Rep
; 7(2): 210-220, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35155860
13.
Renal tubular acidosis (RTA) and kidney stones: Diagnosis and management. / Acidosis tubular renal (ATR) y litiasis renal: Diagnóstico y manejo.
Arch Esp Urol
; 74(1): 123-128, 2021 Jan.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-33459628
14.
The pyrophosphate transporter ANKH is expressed in kidney and bone cells and colocalises to the primary cilium/basal body complex.
Cell Physiol Biochem
; 24(5-6): 595-604, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19910700
15.
Nephrocystin-1 interacts directly with Ack1 and is expressed in human collecting duct.
Biochem Biophys Res Commun
; 371(4): 877-82, 2008 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-18477472
16.
Infrared vibrational spectroscopy: a rapid and novel diagnostic and monitoring tool for cystinuria.
Sci Rep
; 6: 34737, 2016 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27721432
17.
Vascular calcification and bone mineral density in recurrent kidney stone formers.
Clin J Am Soc Nephrol
; 10(2): 278-85, 2015 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25635036
18.
Identification of compound heterozygous KCNJ1 mutations (encoding ROMK) in a kindred with Bartter's syndrome and a functional analysis of their pathogenicity.
Physiol Rep
; 1(6): e00160, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24400161